Novartis (NYSE:NVS) shares beat the market last month, gaining 11% compared to a 3.6% increase in the S&P 500, according to data provided by S&P Global Market Intelligence.
The boost still left shareholders in negative territory, as the stock has trailed the market so far in 2018.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,